Filing Details
- Accession Number:
- 0000899243-19-023854
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-18 18:00:13
- Reporting Period:
- 2019-09-17
- Accepted Time:
- 2019-09-18 18:00:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689575 | Katherine Stueland | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-09-17 | 3,788 | $21.40 | 139,841 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 14, 2018.
- Represents weighted average sale price. Actual sale prices ranged from $21.18 to $21.79.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 111,017 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Billionaire Hedge Funds
